Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell ...

A phase II trial reports success with an innovative immunotherapy for difficult-to-resect basal cell carcinoma, reducing ...

Basal cell carcinoma (BCC) is an epithelial tumour of the skin. It seldom metastasizes, but has the potential for local invasion and destruction. It usually occurs as one or several small pearly ...

According to precedent and due to his status, Yoon will probably be assigned a solitary cell, likely bigger and better appointed than the standard 6.56 square metre (71 square feet) single cells.

People taking metformin had a significantly lower risk of basal cell cancer and a significantly lower risk of squamous cell cancer, results show. “This study strengthens the evidence supporting ...

Basal cell carcinoma is the most common malignancy in humans, and it is also the mostfrequent periocular malignancy. Although a slow-growing tumor, it can lead to significant morbidityin the ...

Discuss the incidence of skin cancer in skin of color. 2. Identify the features of basal and squamous cell cancers in skin ... cancers that are usually not pigmented in Caucasians, a high degree ...